DHA Algal Oil: Empowering Infant Formula Milk Powder To Support Babies’ Healthy Growth

In recent years, the concept of evidence‑based parenting has gained deeper traction, and parents are placing increasingly refined nutritional demands on infant formula milk powder. Docosahexaenoic acid (DHA), a key Omega‑3 long‑chain polyunsaturated fatty acid, is deeply involved in the development of infants' brain and visual systems, making it a core nutrient highly valued in maternal and infant nutrition. Produced via microbial fermentation technology, DHA algal oil has now become the mainstream source of DHA added to infant formula milk powder, thanks to its safety, stability, high bioavailability and other properties.

DHA: A Core Nutrient Supporting Infants' Intellectual and Visual Development

DHA is a major fatty acid component of the human cerebral cortex and the macular region of the retina. During infants' rapid growth and development, its content directly affects the differentiation of nerve cells, the formation of synaptic connections and the maturation of photoreceptor cells, playing a vital role in cognitive ability, memory, learning capacity and visual acuity.

In 2000, Birch et al. conducted a special study recruiting healthy full‑term newborns for long‑term feeding comparison. Infants receiving continuous supplementation of long‑chain polyunsaturated fatty acids (DHA + ARA) showed an average 7‑point higher Mental Development Index (MDI) at 18 months of age compared with the control group, with their visual acuity (VA) also significantly improved[1]. The study also found that the DHA concentration in infants' red blood cells and plasma was positively correlated with their later intellectual development level. Human endogenous synthesis alone cannot meet the developmental needs of young infants, making exogenous dietary supplementation essential.

According to dietary guidelines released by the joint FAO/WHO expert consultation in 2008, healthy infants aged 6–24 months have a recommended daily DHA intake of 10–12 mg per kilogram of body weight. For infants aged 0–6 months, FAO/WHO recommends an intake equivalent to 0.1%–0.18% of total energy intake[2]. For example, a 5‑kg baby needs approximately 50–60 mg of DHA per day, while an 8‑kg baby requires 80–96 mg daily. These standards serve as important references for DHA proportioning in early‑stage infant formula milk powder.

DHA Algal Oil: Multidimensional Advantages Over Traditional Fish Oil

There are marked differences between traditional deep‑sea fish oil and modern DHA algal oil as DHA sources. When evaluated against safety standards, storage requirements, absorption efficiency and other dimensions for infant food, algal oil demonstrates comprehensive leading advantages in compatibility.

Superior Safety Profile

Deep‑sea fish occupy positions in the marine food chain and tend to bioaccumulate heavy metals such as mercury and lead, alongside potential risks including marine microplastics and pathogenic bacteria residues. Even after purification and processing, such hazards cannot be completely eliminated. In contrast, DHA algal oil is produced from microalgae such as Crypthecodinium cohnii and Schizochytrium limacinum using a closed aseptic fermentation process, isolated from marine food‑chain contamination systems. Its residual levels of heavy metals and harmful substances are far below national standard limits, making it more suitable for infants' delicate bodies.

Enhanced Chemical Stability

DHA contains multiple unsaturated double bonds and is highly susceptible to oxidative rancidity when exposed to oxygen, light or high temperatures, resulting in nutrient loss and off‑flavor development. DHA algal oil is first processed into solid particles via microencapsulation technology before being added to milk powder. A protective film forms around the oil, effectively isolating it from external environmental factors. Industry‑measured data shows that under identical storage conditions, the oxidation rate of DHA in encapsulated algal oil is over 60% lower than that of liquid fish oil, perfectly matching the standard 24‑month shelf life of infant formula milk powder.

Higher Bioavailability

DHA in breast milk naturally exists in the triglyceride form, and native DHA in algal oil also adopts a triglyceride structure highly consistent with that of breast‑milk fatty acids, enabling direct digestion and absorption by the infant intestinal tract. Most DHA from traditional fish oil is in the ethyl ester form, which requires secondary intestinal decomposition for absorption, resulting in significantly lower absorption efficiency in infants with underdeveloped digestive systems. Meanwhile, DHA algal oil contains extremely low levels of eicosapentaenoic acid (EPA), avoiding disruption of fatty‑acid balance in infants and offering higher formulation compatibility.

Better Sensory Experience

Deep‑sea fish oil has a strong fishy odor that may alter milk‑powder taste and potentially lead to feeding refusal in babies. Subjected to multi‑stage negative‑pressure deodorization and purification processes, DHA algal oil is nearly free of fishy odor with a mild, natural taste that does not change the original flavor of milk powder, leading to higher acceptability among infants.

Practical Application of DHA Algal Oil in Infant Formula Milk Powder

At present, DHA algal oil is selected as a nutrient‑fortifying raw material by mainstream domestic infant formula milk powder brands. Well‑known domestic and international brands including Wyeth Illuma, MeadJohnson Enfinitas, Abbott Similac Organic, Feihe and Junlebao have completed raw‑material upgrades across their full ranges of infant formula products.

Taking a typical Stage 1 milk powder as an example, every 100 g of powder contains approximately 2000 kJ of energy. Based on this, the DHA addition level per 100 g of powder ranges from 72 mg to 192 mg. Assuming a baby consumes 800 mL of reconstituted milk daily with a mixing ratio of 1 g powder to 7 mL water, the daily powder intake is approximately 114.29 g, providing roughly 82.29–219.43 mg of DHA from milk powder alone, which easily meets the WHO‑proposed intake standard of 10–12 mg/kg body weight.

Furthermore, guided by prevailing scientific research conclusions, the industry commonly adds DHA in combination with ARA at a mainstream ratio of 1:1 to 1:2, replicating the nutrient combination from clinical trials to further amplify their synergistic effects and support infant development.

Practical Guidelines for Selecting DHA‑Algal‑Oil‑Fortified Formula Milk Powder

Precisely Verify Nutrient Content

Check the Nutrition Facts panel on the product packaging to confirm that DHA is algal‑oil‑sourced. Calculate the actual daily intake combined with the baby's body weight and daily milk volume to ensure intake falls within the recommended range of 10–12 mg/kg body weight, avoiding blind pursuit of excessively high addition levels. Prefer products with scientifically compounded DHA and ARA.

Opt for Regularly Qualified Brands

Always select brands holding special registration qualifications for infant formula milk powder. Examine raw‑material test reports to confirm that the purity, heavy‑metal indicators and microbial indicators of DHA algal oil comply with national food‑safety standards, so as to control quality from the source.

Make Personalized Choices Based on Individual Conditions

Preterm infants, those with allergic predispositions and those with weak gastrointestinal functions have special nutritional requirements. Parents are advised to consult pediatricians or professional nutritionists in advance and develop personalized feeding and product‑selection plans according to their baby's physical condition.

With its advantages including safety and purity, property stability and high absorption efficiency, DHA algal oil serves as an ideal raw material for meeting nutritional standards. As research in maternal and infant nutrition deepens and production technologies keep upgrading, DHA algal oil will play an even greater role in infant nutrition and continuously safeguard babies' healthy growth.

Note: This article is for popular‑science reference only and does not constitute medical or professional feeding advice. Please consult professional medical personnel if you have questions about infant nutritional supplementation.

References

[1] Birch, E. E., Garfield, S., Hoffman, D. R., Uauy, R., & Birch, D. G. (2000). A randomized controlled trial of early dietary supply of long‑chain polyunsaturated fatty acids and mental development in term infants. Developmental Medicine & Child Neurology, 42(3), 174‑181.

[2] World Health Organization. (2008). Interim summary of conclusions and dietary recommendations on total fat & fatty acids. From the Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition, 10‑14 November, 2008, WHO, Geneva.